UV spectrophotometric method for simultaneous estimation of Salmeterol xinafoate and Fluticasone propionate in Bulk and Dosage form

International Journal of PharmTech Research

Volumn 3, Issue 3, 2011, Pages 1801-1806

  Kondawar, M S ^a   Shah, R R ^b   Waghmare, J J ^a   Malusare, M K ^a   Shah, N D ^a  

^a Department of Pharmaceutical Quality Assurance ^*  (India)

^b Appasaheb Birnale College of Pharmacy   (India)

Author keywords

Fluticasone propionate; Salmeterol xinafoate; Simultaneous equation method

Indexed keywords

FLUTICASONE PROPIONATE; PHOSPHATE; SALMETEROL XINAFOATE;

ACCURACY; ARTICLE; COST CONTROL; DRUG DETERMINATION; REPRODUCIBILITY; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 79961165300     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Indian pharmacopoeia, The Indian Pharmacopoeia Commission, 2007, volume 2, 1141-1143.
2. Goodman and Gillman's, The Pharmacological Basis of Therapeutics, 2001, 10th Edition, 736-740.
3. Ringdal, N., Eliraz, A., Pruzinec, P., Weber, H.H., Mulder, P.G.H., Akveld, M., Bateman, E.D., The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respiratory Medicines 2007, 97, 234-241.
4. Michael, Y., Chowdhry, B.Z., Ashurst, I.C., Snowden, M.J., Gray, S., The physicochemical properties of salmeterol and fluticasone propionate in different solvent environments, International Journal of Pharmacy, 2000, 200, 279-288.
5. Reddy, M., Rao, K., Rao, S., Rao, M.E., Spectrophotometric method for determination of salmeterol xinafoate, Indian Journal of Pharmaceutical Sciences, 2000, 62, 193-195.
6. Youxua., Xu, Yang, Qin, Philip, Liu. Xin, Determination of salmeterol and its metabolite in rat urine by LC/MS. Journal of Chinese Medical Assocociation.2003, 24, 417.
7. Van Eenoo, P., Deventer, K. and Delbeke, F. T., Quantitative detection of salmeterol after inhalation in equine urine by liquid chromatography/tandem mass spectrometry, Rapid Communications in Mass Spectrometry, 2002, 16: 1755-1759.
8. Di Corcia, D., Morra V., Pazzi M., Vincenti, M., Simultaneous determination of (32-agonists in human urine by fast-gas chromatography/mass spectrometry: method validation and clinical application. Biomedical Chromatography, 2010, 24, 358-366.
9. Damasceno, L., Ventura, R., Ortuño, J., Segura, J., Derivatization procedures for the detection of (32-agonists by gas chromatographic/mass spectrometric analysis, Journal of Mass Spectrometry, 2000, 35, 1285-1294.
10. Zhou Tianshu, Hu Qin, Yu Hui and Fang Yuzhi, Separation and determination of (3-agonists in serum by capillary zone electrophoresis with amperometric detection, Analytica Chimica Acta, 2001, 441(1), 23-28.
11. Krishnaswami, S., Helmut, M.I., Derendorf, H., Hochhaus, G., A sensitive LC-MS-MS method for the quantification of fluticasone propionate in human plasma, Journal of Pharmaceutical and Biomedical Analysis, 2000, 22, 123-129.
12. Laugher, L., Noctor, T.G., Barrow, A., Oxford, J.M., Phillips, T., An improved method for determination of fluticasone propionate in human plasma, Journal of Pharmaceutical and Biomedical Analysis, 1999, 21, 749-758.
13. Murnane, D., Martin, G.P., Marriot, C, Validation of a reverse-phase high performance liquid chromatographic method for concurrent assay of a weak base (salmeterol xinafoate) and a pharmacologically active steroid (fluticasone propionate), Journal of Pharmaceutical and Biomedical Analysis 2006, 18, 1149-1154.
14. Kasaye Lantider, Hymete Ariaya, Mohamed Abdel-Maaboud I., HPTLC- densitometric method for simultaneous determination of salmeterol xinafoate and propionate in dry powder inhalers, Saudi Pharmaceutical Journal, 2010, 18, 153-159.
15. Assi K., Clark, B. J., Altria, K. D., Simultaneous Determination of Basic Drugs and their Acidic Counter-ions by Capillary Electrophoresis, Pharmacy and Pharmacology Communications, 1997, 3, 593-596.
16. Beckett A. H., Stenlake J. B., Principle Pharmaceutical Chemistry, CBS Publishers New Delhi, 2004, 275-314.
17. ICH topic Q-2B Validation of analytical procedure: Methodology CPMP/ICH/281/95) the European agency for the evaluation of medicinal product, Human medicines evaluation unit, 1-9.